Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

Controlled Trial ◽

Stage Ii ◽

Intermediate Risk ◽

Wilms Tumour ◽

Open Label ◽

Faculty Opinions recommendation of Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725634071.793508546 ◽

2015 ◽

Author(s):

Bob Phillips ◽

Jess Morgan

Keyword(s):

Controlled Trial ◽

Stage Ii ◽

Intermediate Risk ◽

Wilms Tumour ◽

Open Label ◽

Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(04)17139-0 ◽

2004 ◽

Vol 364 (9441) ◽

pp. 1229-1235 ◽

Cited By ~ 143

Author(s):

J de Kraker ◽

N Graf ◽

H van Tinteren ◽

F Pein ◽

B Sandstedt ◽

...

Keyword(s):

Controlled Trial ◽

Stage I ◽

Postoperative Chemotherapy ◽

Intermediate Risk ◽

Wilms Tumour ◽

A Phase II, Open Label, Multicenter Randomised Controlled Trial Comparing Hyperthermia Plus Mitomycin To Mitomycin Alone, In Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

http://isrctn.org/> ◽

10.1186/isrctn23639415 ◽

2014 ◽

Cited By ~ 1

Author(s):

Shriram Velamuri

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Open Label ◽

Phase 3 ◽

Dose Dense ◽

Faculty Opinions recommendation of Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12032956.13172054 ◽

2011 ◽

Author(s):

Carlos Seas ◽

Jorge Alave

Keyword(s):

Enteric Fever ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13368964.14739064 ◽

2011 ◽

Author(s):

Vineet Bhandari

Keyword(s):

Mechanical Ventilation ◽

Preterm Infants ◽

Controlled Trial ◽

Open Label ◽

Surfactant Treatment ◽

Randomised Controlled ◽

Spontaneously Breathing

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

D2 Gastrectomy ◽

Faculty Opinions recommendation of Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548124.793152981 ◽

2012 ◽

Author(s):

Mitesh Borad

Keyword(s):

Minimally Invasive ◽

Oesophageal Cancer ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548124.793003137 ◽

2012 ◽

Author(s):

Tim Underwood

Keyword(s):

Minimally Invasive ◽

Oesophageal Cancer ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995519.793476076 ◽

2013 ◽

Author(s):

Kellie Mathis

Keyword(s):

Controlled Trial ◽

Intraepithelial Neoplasia ◽

Anal Intraepithelial Neoplasia ◽

Hiv Positive ◽

Open Label ◽

Sex With Men ◽

Randomised Controlled ◽

Hiv Positive Men